ATLANTA, Nov. 1, 2022 /PRNewswire/ — Novelis Inc. will report its earnings for the second quarter fiscal year 2023 on Tuesday, November 8, 2022. Following the release, Steve Fisher, President and Chief Executive Officer, and Dev Ahuja, Chief Financial Officer, will discuss the results…
Related Posts
CON EDISON DECLARES COMMON STOCK DIVIDEND
NEW YORK, Oct. 20, 2022 /PRNewswire/ — Consolidated Edison, Inc. (Con Edison) (NYSE: ED) declared a quarterly dividend of 79…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
Neues Elektor-Buch: Arduino- und Raspberry Pi-basierte PID-Steuerungen
AACHEN, Deutschland, 22. September 2022 /PRNewswire/ — Neues Elektor-Buch: Arduino- und Raspberry Pi-basierte PID-Steuerungen Was sind PID-Regler? Die PID-Regelung ist…